EP Patent

EP3566697A1 — Tablet formulations of neratinib maleate

Assigned to Wyeth LLC · Expires 2019-11-13 · 7y expired

What this patent protects

The present invention provides coated tablet formulations comprising neratinib and their use for treating cancer.

USPTO Abstract

The present invention provides coated tablet formulations comprising neratinib and their use for treating cancer.

Drugs covered by this patent

Patent Metadata

Patent number
EP3566697A1
Jurisdiction
EP
Classification
—
Expires
2019-11-13
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.